116 related articles for article (PubMed ID: 28489570)
1. Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma.
Huang Y; Zheng J; Chen D; Li F; Wu W; Huang X; Wu Y; Deng Y; Qiu F
Oncotarget; 2017 Jun; 8(25):40693-40704. PubMed ID: 28489570
[TBL] [Abstract][Full Text] [Related]
2. Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians.
Chen J; Yu L; Li D; Gao Q; Wang J; Huang X; Bi G; Wu H; Zhao S
Gene; 2003 Jan; 302(1-2):103-13. PubMed ID: 12527201
[TBL] [Abstract][Full Text] [Related]
3. Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis.
Cheng IK; Ching AK; Chan TC; Chan AW; Wong CK; Choy KW; Kwan M; Lai PB; Wong N
J Pathol; 2010 Feb; 220(3):348-60. PubMed ID: 19927314
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.
Huang Y; Pan J; Chen D; Zheng J; Qiu F; Li F; Wu Y; Wu W; Huang X; Qian J
Oncotarget; 2017 May; 8(22):35973-35983. PubMed ID: 28415592
[TBL] [Abstract][Full Text] [Related]
5. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
7. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
8. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
9. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.
Pan Q; Long X; Song L; Zhao D; Li X; Li D; Li M; Zhou J; Tang X; Ren H; Ding K
Oncotarget; 2016 Jun; 7(25):38487-38499. PubMed ID: 27220887
[TBL] [Abstract][Full Text] [Related]
11. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
Liang J; Lv J; Liu Z
Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
[TBL] [Abstract][Full Text] [Related]
12. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
13. Viral-human chimeric transcript predisposes risk to liver cancer development and progression.
Lau CC; Sun T; Ching AK; He M; Li JW; Wong AM; Co NN; Chan AW; Li PS; Lung RW; Tong JH; Lai PB; Chan HL; To KF; Chan TF; Wong N
Cancer Cell; 2014 Mar; 25(3):335-49. PubMed ID: 24582836
[TBL] [Abstract][Full Text] [Related]
14. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
[TBL] [Abstract][Full Text] [Related]
15. Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.
Zhang H; Ye J; Weng X; Liu F; He L; Zhou D; Liu Y
Cancer Genet; 2015 Oct; 208(10):482-91. PubMed ID: 26271415
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method.
Dong XY; Pang XW; Yu ST; Su YR; Wang HC; Yin YH; Wang YD; Chen WF
Int J Cancer; 2004 Nov; 112(2):239-48. PubMed ID: 15352036
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.
Cao L; Zhang Q; Cheng S; Chen Z; Hua Z; Yang J; Liu D; Cui N
Oncol Rep; 2016 Nov; 36(5):2619-2624. PubMed ID: 27667473
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.
Simon EP; Freije CA; Farber BA; Lalazar G; Darcy DG; Honeyman JN; Chiaroni-Clarke R; Dill BD; Molina H; Bhanot UK; La Quaglia MP; Rosenberg BR; Simon SM
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):E5916-25. PubMed ID: 26489647
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).
Xu W; Huang H; Yu L; Cao L
Med Oncol; 2015 Apr; 32(4):96. PubMed ID: 25731616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
